Piedmont Capital Management (North Carolina)’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Piedmont Capital Management (North Carolina)'s JNJ Position: Q2 2026 in Review
Piedmont Capital Management (North Carolina) reduced its Johnson & Johnson (JNJ) stake by 18% in Q2 2026, selling an estimated $97K and leaving 1,848 shares worth $469K. The position accounts for 0.29% of the portfolio, ranked #60.
Piedmont Capital Management (North Carolina) first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. The position peaked at $553K in Q1 2026. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Piedmont Capital Management (North Carolina) held 1,848 shares of Johnson & Johnson worth $469K as of Q2 2026.
- Piedmont Capital Management (North Carolina) sold 416 Johnson & Johnson shares in Q2 2026, an estimated $97K.
- Johnson & Johnson made up 0.29% of Piedmont Capital Management (North Carolina)'s portfolio in Q2 2026, its #60 holding.
- Piedmont Capital Management (North Carolina) first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
- Piedmont Capital Management (North Carolina)'s Johnson & Johnson position peaked at $553K in Q1 2026.
- 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Piedmont Capital Management (North Carolina)'s 13F filing for Q2 2026, filed 13 Aug 2026.